7, 2023 — Millions of Americans have inflammatory bowel disease (IBD), which occurs in one of two forms: Crohn's disease or ulcerative colitis. Though the two have similar symptoms, they require ...

Managing inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may soon become more advanced and ...

Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

Researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically ...

Inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis, affects millions of ...

Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...

A study by University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue ...

The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease ...

A device used in South Jersey is a game-changer for people with inflammatory bowel disease as an alternative to invasive ...

The top 5 biosimilar conference articles in 2024 highlight significant progress in the biosimilar landscape, including ...

Teva Pharmaceuticals and Sanofi announced that their Phase 2b RELIEVE UCCD study met primary endpoints for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD) using duvakitug ...